The design of the VISEP trial. Critical appraisal;Studienprotokoll der VISEP-studie. Eine kritische stellungnahme

Anaesthesist

Volumn 56, Issue 1, 2007, Pages 71-77

  Zander, R ^a   Boldt, J ^b   Engelmann, L ^c   Mertzlufft, F ^d   Sirtl, C ^e   Stuttmann, R ^f  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Klinikum   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d EVANGELISCHES KRANKENHAUS   (Germany)

^e ST JOSEF HOSPITAL   (Germany)

^f BG KLINIKEN BERGMANNSTROST   (Germany)

Author keywords

Hydroxyethyl starch (HES); Multicenter study; Sepsis; Study appraisal; Study design; Volume replacement therapy

Indexed keywords

HEMOHES; HETASTARCH; LACTIC ACID; NEUTRAL INSULIN; STEROFUNDIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; BIODEGRADABILITY; CLINICAL TRIAL; COLLOID; CREATININE BLOOD LEVEL; CRYSTALLOID; DEHYDRATION; DIABETES MELLITUS; DISEASE MARKER; GLUCONEOGENESIS; HUMAN; HYPERGLYCEMIA; HYPOXIA; INSULIN TREATMENT; KIDNEY FUNCTION; METHODOLOGY; MOLECULAR WEIGHT; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PUBLICATION; RESUSCITATION; REVIEW; RISK FACTOR; SEPSIS; SEPTIC SHOCK; TREATMENT OUTCOME; URINARY EXCRETION;

BLOOD GLUCOSE; COLLOIDS; ENDPOINT DETERMINATION; HETASTARCH; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE; ISOTONIC SOLUTIONS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; LACTIC ACID; OXYGEN CONSUMPTION; PLASMA SUBSTITUTES; PROSPECTIVE STUDIES; RESEARCH DESIGN; SEPSIS; SHOCK, SEPTIC;

EID: 33846566844     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-006-1122-4     Document Type: Review

References (15)

1. B. Braun Melsungen AG (2006) Basics of i.v. therapy, volume replacement 8. http://www.iv-partner.com. Gesehen 26.11.2006
2. Bloos F (2006) Kristalloide vs. Kolloide bei Sepsis - Ergebnisse der VISEP-Studie. Abstracts des DAC Leipzig 2006 (H-204.1)
3. Bloos F, Brunkhorst FM, Meier-Hellmann A, Reinhart K (2002) Empfehlungen zur Diagnostik und Therapie, Kompetenznetz Sepsis 2002. http://webanae.med.uni- jena.de/WebObjects/DSGPortal.woa/WebServerResources/sepnet/visep.html. Gesehen 26.11.2006
4. Brunkhorst FM (2006) Intensivierte Insulintherapie - Ergebnisse der VISEP-Studie. Abstracts des DAC Leipzig 2006 (H-308.1)
5. Brunkhorst FM, Werdan K (2006) Intensivmedizin - Nach den positiven Studien kommen die Fragen. Dtsch Med Wochenschr 131: 1441-1444
6. Brunkhorst FM, Kuhnt E, Engel C et al., and the German Competence Network Sepsis (SepNet) (2005) Intensive insulin therapy in patient with severe sepsis and septic shock is associated with an inreased rate of hypoglycemia - results from a randomized multicenter study (VISEP). Infection 33 [Suppl 1]: 19
7. Drummer C, Gerzer R, Heer M et al. (1992) Effects of an acute saline infusion in fluid and electrolyte metabolism in humans. Am J Physiol 262: F744-F754
8. Larsen R (2002) Anästhesie, 7. Aufl. Urban & Fischer, München
9. Lorentz A (2003) Volumenersatz mit kolloidalen Plasmaersatzmitteln. In: List W, Osswald PM, Hornke I (Hrsg) Komplikationen und Gefahren in der Anästhesie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo
10. Ragaller MJR, Theilen H, Koch T (2001) Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol 12: S33-S39
11. Reinhart K (2006) Fluid therapy in sepsis - VISEP study results (SepNet). Symposium Intensivmedizin, Bremen
12. Schortgen F, Lacherade JC, Bruneel F et al. (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomized study. Lancet 357: 911-916
13. Wilkes NJ, Woolf R, Mutch M et al. (2001) The effect of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 93: 811-816
14. Zander R (2006) Flüssigkeitstherapie. Bibliomed, Melsungen. Download: www.physioklin.de
15. Zander R, Adams HA, Bold J et al. (2005) Forderungen und Erwartungen an einen optimalen Volumenersatz. Anästhesiol Intensivmed Notfallmed Schmerzther 40: 701-719